VivoSim Labs, Inc. Common Stock —— 季度财务报表 (NASDAQ:VIVS) | MetaTrader

展开完整图表

Financials

概览声明统计 Documents

每季度年度

Market Capitalization 4.16 M
Employee 11
Founded 2007
CEO N/A
Website www.organovo.com
Headquarter Delaware, United States
FIGI BBG001M8GFD0
Industry 药品制造—常规

总收入

净利润

每股基本收益（基本 EPS）

总债务

自由现金流

现金及现金等价物

市盈率

-0.24

市销率

—

Related tickers

	#	姓名	价格	24小时 %	7天 %	一个月 %	一年 %	市值	最近7天
	4893	KAPA Kairos Pharma, Ltd. Common Stock	1.58 USD	-2.47%	+532.00%	+426.67%	+172.41%	5.35 M USD
	4957	APUS Apimeds Pharmaceuticals US, Inc. Common Stock	2.74 USD	-20.81%	-41.08%	-45.53%	+109.16%	4.13 M USD
	5031	PPCB Propanc Biopharma, Inc. - Common Stock	1.03 USD	-8.85%	-70.99%	+0.98%	-63.35%	2.35 M USD
	5049	DCOY Decoy Therapeutics Inc. - Common Stock	2.97 USD	-2.94%	+2.06%	-30.77%	+267.21%	1.95 M USD